Top Biotech Companies (3,704)
MTF Biologics is a global nonprofit organization on the forefront of saving and healing lives through innovations in tissue and organ donation, transplantation, and research. Based in Edison, N.J. it is a national consortium comprised of leading organ procurement organizations, tissue recovery organizations and academic medical institutions. For more information, visit www.mtfbiologics.org.
MTF Biologics's Top Stability & Growth Strengths
Resilient & Sustainable Growth: Recent Form 990 filings indicate total revenue increased from FY2022 through FY2024 to a new high, with annual allograft distribution volumes remaining substantial. As a nonprofit reinvesting in research and operating across multiple clinical segments, growth appears steady and durable.
Strategic Partnerships: Long-term and expanded agreements with Orthofix, Centurion Therapeutics, and Kolosis BIO broaden distribution and add new allograft offerings, while OEM processing relationships (e.g., DBX) deepen channel access. These partnerships support consistent demand and market reach across orthopedics, wound care, and cardiac surgery.
Strong Market Position & Advantage: The organization is frequently described as the world’s largest tissue bank with one of the broadest allograft portfolios, extensive accreditation, and millions of grafts delivered. Consistent inclusion as a major player across relevant market reports reinforces recognized scale and presence despite sizable competitors.
Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. Compared to standard microfluidic methods, the Lightcast platform offers the ability to run a broader range of assays and to precisely control and track the number, occupancy, location, and movement of each droplet. The unprecedented scalability and flexibility of this approach will help advance translational...
Most agencies hand over code and walk away, leaving you to build the business yourself. We work differently, measuring our success by your traction - real users on a live product and real signs that the business is growing. Every engagement is built around a guaranteed outcome: For founders starting from scratch, our TractionLab program puts a real user on...
Precision Biologics is a Biotechnology company located in 5910 N Central Expy, Dallas, Texas, United States.
Kineta is a privately held emerging biotech company that was founded in 2008. Our mission is to develop novel immunotherapies that transform patients’ lives.
Synchron is a leading implantable brain computer interface company. The stentrode is the first commercial implantable brain computer interface to receive an FDA IDE for in human clinical trials.
Better Therapeutics ("Better") is developing first-in-class prescription digital therapeutics to deliver behavioral therapy to patients. Led by an experienced team of biotechnology executives with funding from top-tier industry investors, Better went public through a merger with SPAC Mountain Crest Acquisition Corp. (NASDAQ: MCAD) during the fall of 2021. Better was founded upon the realization that nearly half a trillion dollars are...
Evestra, Inc., a pharmaceutical company, develops and commercializes short-and long-term products in the female health care therapeutic
Thermo Fisher Scientific provides industry-leading pharma services solutions for drug development, clinical trial logistics and commercial manufacturing to customers through our Patheon brand. With more than 65 locations around the world, we provide integrated, end-to-end capabilities across all phases of development, including API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics services and commercial manufacturing and packaging. Built...
Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis®, our innovative health intelligence platform, is enabling us to generate a more complete understanding of...
The MicroByre team makes pets out of bacteria. The vast majority of prokaryotes on the planet are not currently considered cultivable, let alone genetically modifiable. MicroByre domesticates and then genetically engineers otherwise reluctant, recalcitrant, and rebellious bacteria. We get them to eat out of our hands. With friends like these, who needs petroleum? Newly cooperative bacteria will help us replace ancient...
Great Basin Corporation is a life sciences company commercializing technologies for the molecular, rapid diagnostic testing market.
Diverse Biotech is an innovative biopharmaceutical research company committed to discovering
BioRAFT designs enterprise level SaaS based software to mitigate risk for laboratory researchers and Environmental Health and Safety (EH&S) professionals. Our management, product development, customer success and sales teams come from academic and pharmaceutical research, scientific software, education, EH&S, healthcare, and aerospace industries.
Since 1996, Minnetronix Medical has accelerated medical device breakthroughs as a design, development and manufacturing partner to leading device companies around the world. Today, through life-cycle efficiency, opportunity realization, and increased utility, the organization is creating value in key technology segments, including RF energy, fluid and gas management, optical systems, and stimulation and active wearables. From design and manufacturing services...
Genesis Therapeutics is unifying AI and biotech to accelerate and optimize drug discovery. We pioneer novel deep learning and molecular simulation techniques to accelerate the development of new medicines. Genesis raised its $52M Series A from top tech + biotech investors, Andreessen Horowitz, Rock Springs, and T. Rowe Price. Story: https://techcrunch.com/2020/12/02/genesis-therapeutics-raises-52m-a-round-for-its-ai-focused-drug-discovery-mission/ We deploy our technology to accelerate a pipeline of several internal drug programs. Furthermore,...
Emulate Inc. is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health. Our lab-ready Human Emulation System® includes three components: Zoë® Culture Module, Organ-Chips, and analytical software applications. The platform provides a window into the inner workings of human biology and disease—offering researchers a new technology designed to...
